Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer

Conditions:   Anatomic Stage I Breast Cancer AJCC v8;   Anatomic Stage II Breast Cancer AJCC v8;   Anatomic Stage III Breast Cancer AJCC v8;   HER2-Negative Breast Carcinoma;   Hormone Receptor-Positive Breast Carcinoma;   Invasive Breast Carcinoma Interventions:   Drug: Letrozole;   Drug: Simvastatin Sponsors:   Emory University;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials